Medicus TYVASO Information Architecture & Site Map v.1.4 May 14, 2009

Transcription

1 Medicus TYVASO Site Design - May 19, version 1.4 Page 1 of 10 Medicus TYVASO Architecture & v.1.4 May 14, 2009 Full

2 Medicus TYVASO Site Design - May 19, version 1.4 Page 2 of 10 The Architecture Approach Architecture an iterative process of integrating project goals, users needs, and site content into a holistic system that is easy-touse and well organized. Once the goals, users, and site content is established, n Architect begins t conceive of what the user seeks to access from the site. We consider different ways a user can access information or what would motivate them into the content. This is when we draw up user profiles and use case scenarios. These documents offer a description of the experience of the website. After which, we organize and establish content groups into the site structures, taxonomies, and nomenclatures in sitemap documentation. The process of planning the site and its contents continues by diagramming each template into a gray-scale box diagrams called wireframes. Overall, the IA documents are the blueprints of the website upon which all other aspects are built - form, function, metaphor, navigation and interface, interaction, and visual design.

3 Medicus TYVASO Site Design - May 19, version 1.4 Page 3 of 10 Structural Overview Architecture Concept: Design and program a full branded website for TYVASO that will go live at the commercial launch (timed to launch meeting in June) of TYVASO. The site should open directly into the patient/caregivers landing page, where there will be a link for physicians to navigate to their sub-site. The website will be divided in to the following first tier sections: 0.0 Home Page Site overview, link to Physician / Patient caregiver sections of site. 1.0 About PAH About PAH and pages on; the disease state, Prostacyclin: A unique mechanism of action and combination therapy in PAH. 2.0 About TYVASO Overview of TYVASO and pages on; Indication for TYVASO, TRIUMPH-1 clinical trial, dosage & administration. 3.0 TYVASO Inhalation System Overview of the TYVASO Inhalation System and pages on; important features, components, using, care and cleaning and ordering the TYVASO Inhalation System. 4.0 Patient resources/services Overview of patient resources and services and page on; getting patients started with TYVASO and additional patient resources. 5.0 FAQs Frequently Asked Questions on PAH and TYVASO. 6.0 on prescribing TYVASO.

4 Medicus TYVASO Site Design - May 19, version 1.4 Page 4 of Home Page - Overview of Global Navigation Patient/ Caregiver Section 0.0a Physician Confirmation Full Physician Section 0.0b About PAH About TYVASO TYVASO Inhalation System Patient resources/ services FAQs 1.0b 2.0b 3.0b 4.0b 5.0b Global Navigation - Appears prominently on all pages of site

5 Medicus TYVASO Site Design - May 19, version 1.4 Page 5 of About PAH About PAH 1.0b Full Established Prostacylin Efficacy 1.1b Combination therapy in PAH 1.2b

6 Medicus TYVASO Site Design - May 19, version 1.4 Page 6 of About TYVASO About TYVASO Indication 2.0b Full TRIUMPH-1 clinical trial Dosage & administration 2.1b 2.2b Tabbed Navigation Structure on page 2.1b Tabbed Navigation Structure on page 2.2b Study design Efficacy results Long-term data Safety profile Potential benefits of inhalation delivery How TYVASO is dosed How TYVASO is supplied 2.1.1b 2.1.2b 2.1.3b 2.1.4b 2.2.1b 2.2.2b 2.2.3b Content on page 2.1.2b to include: Improvements in exercise capacity Full Reduction in serum NT pro-bnp Improvements in quality of life

7 Medicus TYVASO Site Design - May 19, version 1.4 Page 7 of TYVASO Inhalation System TYVASO Inhalation System 3.0b Full Overview Important features Components Use Care and Cleaning Ordering 3.1b 3.2b 3.3b 3.4b 3.5b 3.6b Will include video or Flash animation which demonstrates the features, use and care of the TYVASO deliver platform. These can be used for both Doctor and Patient / Caregiver sites.

8 Medicus TYVASO Site Design - May 19, version 1.4 Page 8 of Patient resources/services Patient resources/ services 4.0b Content on page 4.0b to include: Educational Website Links: PHA NHLBI Full Patient Materials: Patient Video Patient Brochure Patient Treatment Tracker

9 Medicus TYVASO Site Design - May 19, version 1.4 Page 9 of FAQs FAQs 5.0b Full User will be able to sort list of FAQ s by topic TBD What is TYVASO? For which indication is TYVASO approved? What is the mechanism of action for TYVASO? What is dosing regimen for TYVASO? How is TYVASO titrated? What is the highest daily dose of TYVASO studied? How is TYVASO supplied? How do patients inhale TYVASO? What makes the TYVASO Inhalation System unique? What are the important features of the TYVASO Inhalation System? How much time does each treatment session require? What are the potential benefits of an inhaled form of prostacyclin? What is the significance of combination therapy in the treatment of PAH? How was TYVASO studied? How was the primary endpoint of improvement in exercise capacity measured? What were the notable secondary efficacy improvements in TRIUMPH-1? What is the significance of the placebo-corrected median change from baseline in peak 6MWD in patients with background bosentan and sildenafil? How were peak and trough efficacy values measured? Are there any data to suggest benefits of long-term treatment with TYVASO? How rapidly does TYVASO start working? What is the half-life of TYVASO? How is TYVASO metabolized? Does TYVASO inhibit cytochrome P-450 enzymes? Does TYVASO interact with other medications? How is TYVASO excreted? What are the most common adverse reactions to TYVASO? Are there any contraindications to TYVASO? Is routine liver function testing required in patients taking TYVASO? Can TYVASO be used during pregnancy? How are TYVASO and the TYVASO Inhalation System ordered? How can I get patients started with TYVASO?

10 Medicus TYVASO Site Design - May 19, version 1.4 Page 10 of Full Full English - En Full Spanish - Sp